| Olesya Shcheglovitova, RPH | |
|
4675 S Holladay Blvd, Holladay, UT 84117-5268 | |
| (385) 257-8310 | |
| (385) 257-8311 |
| Full Name | Olesya Shcheglovitova |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4675 S Holladay Blvd, Holladay, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881321206 | NPI | - | NPPES |
| 10462674-1701 | Medicaid | UT | |
| 104626741701 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10462674-1701 (Utah) | Secondary |
| 183500000X | Pharmacist | 104626741701 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Olesya Shcheglovitova, RPH 4675 S Holladay Blvd, Holladay, UT 84117-5268 Ph: (385) 257-8310 | Olesya Shcheglovitova, RPH 4675 S Holladay Blvd, Holladay, UT 84117-5268 Ph: (385) 257-8310 |
News Archive
Following the widely publicised US Centers for Disease Control and Prevention report in February that the current season's flu vaccine is only 9% effective in the over-65 population, Immune Targeting Systems Limited, today announces positive data from a Phase 2a trial with the Company's lead pan-strain influenza A T-cell vaccine, Flunisyn, in the elderly population.
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with HIV/AIDS.
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
Skanska has been awarded a contract to build a world-class cancer clinic in London for University College Hospitals NHS Foundation Trust. The contract amount is GBP 61 M, approximately SEK 740 M, which will be included in third-quarter order bookings.
› Verified 9 days ago
Joseph Dratter, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4714 S Holladay Blvd, Holladay, UT 84117 Phone: 801-278-9767 | |
Dr. Jameson Allen Rice, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4675 S Holladay Blvd, Holladay, UT 84117 Phone: 385-257-8312 Fax: 385-257-8311 | |
Judy Huynh Chung, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4714 Holladay Blvd, Holladay, UT 84117 Phone: 801-278-9767 | |
Alison Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4714 Holladay Blvd, Holladay, UT 84117 Phone: 801-278-9767 | |
Lisa B. Wall, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4714 Holladay Blvd, Holladay, UT 84117 Phone: 801-278-9767 | |
David Clark Terry, BS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4690 Holladay Blvd, Holladay, UT 84117 Phone: 801-278-0411 | |
Clay Denison, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4714 S Holladay Blvd, Holladay, UT 84117 Phone: 801-278-9767 |